Skip to content

Internet Cognitive Behavior Therapy (CBT) for Body Dysmorphic Disorder (BDD)

Internet-based Cognitive Behavior Therapy for Body Dysmorphic Disorder: A Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01850433
Enrollment
23
Registered
2013-05-09
Start date
2013-03-31
Completion date
2014-03-31
Last updated
2017-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Body Dysmorhpic Disorder

Keywords

BDD, CBT

Brief summary

The primary aim is to develop, and test the feasibility, of a novel and protocol-based cognitive behaviour therapy (CBT) treatment for body dysmorphic disorder (BDD) administered via the Internet.

Interventions

BEHAVIORALInternet based CBT for body dysmorphic disorder

Sponsors

Karolinska Institutet
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* outpatients * male or female -≥ 18 years * currently living in Stockholm county * primary diagnosis of BDD according to the DSM-IV-TR * signed informed consent * regular access to a computer with Internet access and skills to use the web.

Exclusion criteria

* psychotropic medication changes within two months prior to the treatment * completed CBT for BDD within the last 12 months * BDD-YBOCS \< 12 at psychiatrist visit * other primary axis I diagnosis * current substance dependence * lifetime bipolar disorder or psychosis * suicidal ideation * Axis II diagnosis that could jeopardize treatment participation * other current psychological treatment that could affect BDD symptoms

Design outcomes

Primary

MeasureTime frame
Body dysmorphic disorder symptomsMeasured after 12 weeks of treatment, and after 3 months after treatment

Secondary

MeasureTime frame
Functioning and life satisfactionAfter 12 weeks of treatment, and 3 months after treatment
Depressive symptomsAfter 12 weeks of treatment, and 3 months after treatment

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026